Calmerceuticals has introduced a new women’s health supplement aimed at addressing the physical and emotional changes associated with perimenopause. The Sydney-based wellness brand officially launches Pericalm Formula on July 10, 2025, positioning the product as a more rigorous, science-backed alternative in a market often driven by wellness trends.
Founder Rose Rayner said the company developed the product to help close the gap in clinically relevant, locally made options for women experiencing hormonal changes. “Supplements should be transparent, effective, and scientifically proven — not based on trends,” she said.
Pericalm contains a blend of clinically studied ingredients, including Verisol collagen, white grape seed extract, activated B vitamins, magnesium lactate, vitamin D3, and a plant-based complex called EpiBright. The formulation is designed to support hormone metabolism, mood stability, skin health and sleep.
While the product enters an increasingly competitive category, Rayner said Australia has traditionally lagged behind international markets like the EU and US in women’s supplement innovation. “We’re not just improving the category — we’re setting a new benchmark,” she said.
Pericalm will be sold online at calmerceuticals.com, priced at $99 AUD or $89 AUD for subscribers.
Calmerceuticals was founded with the goal of bridging the gap between scientific research and natural wellness. The company says it prioritises formulation transparency and measurable results across its product range.
Read the WINTER ’25 issue of Retail Beauty below:
- For more news and updates, subscribe to our weekly newsletter
- Follow us on Instagram
- Like us on Facebook
- Connect with us on LinkedIn